Risk stratification in follicular lymphoma

被引：14

作者：

Casulo, Carla ^{[1
]}

机构：

[1] Univ Rochester, James P Wilmot Canc Inst, 601 Elmwood Ave Box 704, Rochester, NY 14642 USA

来源：

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2018年 / 31卷 / 01期

关键词：

Follicular lymphoma; Risk factors; Prognosis; INTERNATIONAL PROGNOSTIC INDEX; NON-HODGKIN-LYMPHOMA; FONDAZIONE ITALIANA LINFOMI; NATIONAL LYMPHOCARE; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; CELL LYMPHOMAS; FOLL05; TRIAL; T-CELLS; PET-CT;

D O I：

10.1016/j.beha.2017.11.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Advances in the understanding of FL biology, molecular characteristics and clinical risk factors are further highlighting the heterogeneity of this disease. Historically used prognostic factors were broadly based on clinical and laboratory features at the time of diagnosis. However novel prognostic factors are emerging that can be studied at the time of diagnosis, and relapse, and use a variety of tools including gene alterations and diagnostic imaging. These novel discoveries are being implemented into daily practice with the ultimate goal of providing a precise, individualized approach to every patient with FL (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：15 / 22

页数：8

共 40 条

[1]

Barr PLH, 2016, SEQUENTIAL RCHOP RAD

[2]

Barrington SF, 2014, J CLIN ONCOL OFF J A

[3] The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome [J].

Buske, Christian ;

Hoster, Eva ;

Dreyling, Martin ;

Hasford, Joerg ;

Unterhalt, Michael ;

Hiddemann, Wolfgang .

BLOOD, 2006, 108 (05) :1504-1508

[4] Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling [J].

Byers, Richard J. ;

Sakhinia, Ebrahim ;

Joseph, Preethi ;

Glennie, Caroline ;

Hoyland, Judith A. ;

Menasce, Lia P. ;

Radford, John A. ;

Illidge, Timothy .

BLOOD, 2008, 111 (09) :4764-4770

[5] High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma [J].

Carreras, Joaquim ;

Lopez-Guillermo, Armando ;

Fox, Bridget C. ;

Colomo, Lluis ;

Martinez, Antonio ;

Roncador, Giovanna ;

Montserrat, Emili ;

Campo, Elias ;

Banham, Alison H. .

BLOOD, 2006, 108 (09) :2957-2964

[6] Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study [J].

Casulo, C. ;

Day, B. ;

Dawson, K. L. ;

Zhou, X. ;

Flowers, C. R. ;

Farber, C. M. ;

Hainsworth, J. D. ;

Cerhan, J. R. ;

Link, B. K. ;

Zelenetz, A. D. ;

Friedberg, J. W. .

ANNALS OF ONCOLOGY, 2015, 26 (11) :2311-2317

[7] Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study [J].

Casulo, Carla ;

Byrtek, Michelle ;

Dawson, Keith L. ;

Zhou, Xiaolei ;

Farber, Charles M. ;

Flowers, Christopher R. ;

Hainsworth, John D. ;

Maurer, Matthew J. ;

Cerhan, James R. ;

Link, Brian K. ;

Zelenetz, Andrew D. ;

Friedberg, Jonathan W. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) :2516-U55

[8] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells [J].

Dave, SS ;

Wright, G ;

Tan, B ;

Rosenwald, A ;

Gascoyne, RD ;

Chan, WC ;

Fisher, RI ;

Braziel, RM ;

Rimsza, LM ;

Grogan, TM ;

Miller, TP ;

LeBlanc, M ;

Greiner, TC ;

Weisenburger, DD ;

Lynch, JC ;

Vose, J ;

Armitage, JO ;

Smeland, EB ;

Kvaloy, S ;

Holte, H ;

Delabie, J ;

Connors, JM ;

Lansdorp, PM ;

Ouyang, Q ;

Lister, TA ;

Davies, AJ ;

Norton, AJ ;

Muller-Hermelink, HK ;

Ott, G ;

Campo, E ;

Montserrat, E ;

Wilson, WH ;

Jaffe, ES ;

Simon, R ;

Yang, LM ;

Powell, J ;

Zhao, H ;

Goldschmidt, N ;

Chiorazzi, M ;

Staudt, LM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) :2159-2169

[9] Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High-Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS [J].

Dupuis, Jehan ;

Berriolo-Riedinger, Alina ;

Julian, Anne ;

Brice, Pauline ;

Tychyj-Pinel, Christelle ;

Tilly, Herve ;

Mounier, Nicolas ;

Gallamini, Andrea ;

Feugier, Pierre ;

Soubeyran, Pierre ;

Colombat, Philippe ;

Laurent, Guy ;

Berenger, Nathalie ;

Casasnovas, Rene-Olivier ;

Vera, Pierre ;

Paone, Gaetano ;

Xerri, Luc ;

Salles, Gilles ;

Haioun, Corinne ;

Meignan, Michel .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) :4317-4322

[10] Analysis of multiple biomarkers, shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL) [J].

Farinha, P ;

Masoudi, H ;

Skinnider, BF ;

Shumansky, K ;

Spinelli, JJ ;

Gill, K ;

Klasa, R ;

Voss, N ;

Connors, JM ;

Gascoyne, RD .

BLOOD, 2005, 106 (06) :2169-2174

← 1 2 3 4 →